Vimarsana
Biggest News Aggregation in the World

Aditxt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aditxt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aditxt Today - Breaking & Trending Today

Aditxt, Inc. (NASDAQ:ADTX) Sees Large Growth in Short Interest - Vimarsana News

Aditxt, Inc. (NASDAQ:ADTX) Sees Large Growth in Short Interest

Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 212,300 shares, an increase of 988.7% from the March 31st total of 19,500 shares. Approximately 10.8% of the company’s stock are sold short. Based on an average daily trading volume, […]

Source: wkrb13.com
Appili Therapeutics to be acquired by Virginia-based life sciences company Aditxt - Vimarsana News

Appili Therapeutics to be acquired by Virginia-based life sciences company Aditxt

Halifax-based biopharmaceutical company Appili Therapeutics has agreed to be acquired by Virginia life sciences company Aditxt in a nearly $17-million CAD deal.

Aditxt Gains 17% As It Agrees To Buy Appili Therapeutics - Vimarsana News

Aditxt Gains 17% As It Agrees To Buy Appili Therapeutics

Shares of Aditxt, Inc. (ADTX) gained over 17% on Tuesday morning after the company agreed to buy Appili Therapeutics (APLIF) ADTX is currently trading at $3.7233, up $0.

Aditxt Buys MDNA Life Sciences for $25 Million - Vimarsana News

Aditxt Buys MDNA Life Sciences for $25 Million

By Chris Wack Aditxt has acquired MDNA Life Sciences for consideration of 50,000 shares of Aditxt stock, warrants to buy 50,000 Aditxt shares, 5,000 shares...

Aditxt Shares Drop 24% After Pricing of Private Placement - Vimarsana News

Aditxt Shares Drop 24% After Pricing of Private Placement

By Chris Wack Aditxt shares were down 24% to $5.05 in premarket trading after the company on Friday entered into definitive agreements for the purchase and...